Advisor Group Holdings, Inc. Brainstorm Cell Therapeutics Inc. Call Options Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCLI
# of Institutions
12Shares Held
599KCall Options Held
32.9KPut Options Held
7.5K-
Black Rock Inc. New York, NY386KShares$718,7300.0% of portfolio
-
Raymond James & Associates St Petersburg, FL95.2KShares$176,9840.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA22.7KShares$42,1580.01% of portfolio
-
Weaver Consulting Group15.6KShares$29,0580.01% of portfolio
-
S.C. Financial Services, Inc.12.7KShares$23,5950.03% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $67.9M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...